The Checkup by Singlecare

MAY 8, 2025

GLP-1 receptor agonistssuch as Ozempic and Wegovy have become extremely popular over the last few years. Initially approved by the FDA for Type 2 diabetes, GLP-1s have shown efficacy and soared to popularity for their weight loss benefits. In a KFF poll, one in eight adults reported ever taking a GLP-1 agonist. While GLP-1s are effective at lowering weight, hemoglobin A1C levels, and cardiovascular risk, their effects are only sustained if taken continuously.

Dosage 52

Dosage FDA 52

Drug Topics

MAY 6, 2025

Among patients treated with buprenorphine, 25.4% experienced adverse pregnancy outcomes, compared to 30.8% in the untreated group.

315

315

Pharmafile

MAY 6, 2025

Sanofi and Clayton, Dubilier & Rice (CD&R) have officially closed the sale of a controlling 50% stake in Opella, Sanofis consumer healthcare division, positioning Opella as a new independent leader in the global consumer health space. The deal brings Sanofi approximately 10bn in net cash proceeds. Sanofi retains a 48.2% share in Opella, with Bpifrance […] The post Sanofi and CD&R finalise Opella deal, launching global consumer healthcare giant appeared first on Pharmafile.

100

100

European Pharmaceutical Review

MAY 5, 2025

New clinical findings show that Johnson & Johnsons monoclonal antibody Tremfya (guselkumab) enabled sustained clinical and endoscopic efficacy for ulcerative colitis patients at two years. This is based on the long-term extension study of the Phase III QUASAR trial , which evaluated adults with moderately-to-severely active forms of the disease.

FDA 64

FDA 64

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

The Checkup by Singlecare

MAY 6, 2025

Zinc is an essential nutrient for many bodily processes, such as immune function and wound healing. Your body doesnt naturally produce it, so you must consume it in the foods you eat or take a supplement to avoid a zinc deficiency. Luckily, many foods you probably already eat are chock-full of zinc, including seafood, red meat, poultry, whole grains, and legumes.

Immunization 85

Immunization Mayo Clinic Dosage 85

Drug Topics

MAY 9, 2025

Vin Gupta, MD, former Chief Medical Officer at Amazon Pharmacy and renowned US medical analyst, discusses pharmacists ability to reach communities and address social determinants of health.

247

247

STAT

MAY 9, 2025

Less than two years ago, I completed a three-year emergency medicine residency and, after passing written and oral board exams, became a board-certified emergency physician. Now, the Accreditation Council for Graduate Medical Education is claiming that three years of personal and financial sacrifice are not enough.  The ACGME reviews each specialty’s program requirements every 10 years, and it recently released their proposed updates for emergency medicine.

Hospitals 105

Hospitals 105

The Checkup by Singlecare

MAY 5, 2025

Phenobarbital belongs to a drug class called barbiturates , which are primarily used as seizure medications. Barbiturates are sedative-hypnotic medications, meaning they help you feel sleepy and relaxed. Phenobarbital is FDA approved to prevent and treat several types of seizure disorders, including epilepsy and status epilepticus. The anti-epileptic is also used in addiction treatment for the management of withdrawal symptoms associated with benzodiazepine and alcohol dependence.

Dosage 52

Dosage Controlled Substances Communication Hospitals 52

Drug Topics

MAY 9, 2025

Stanley V. Campbell, Jr., CEO of EagleForce Associates, Inc., and Yi Deng, PhD, Senior Vice President of Engineering at EagleForce, discuss the basics of AI and how its assisting with compliance.

394

394

European Pharmaceutical Review

MAY 5, 2025

Drug delivery technology is undergoing rapid innovation worldwide. Pharmaceutical manufacturers are adopting advanced delivery platforms to improve drug efficacy and patient compliance, while scaling production for global distribution. In fact, industry analysis shows drug delivery innovation is at an all-time high globally. From nanotechnology-based carriers to smart inhalation devices, these developments are reshaping how therapies are manufactured and administered.

89

89

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

MAY 9, 2025

Loss of services and support systems will result in the rollback of advancements made around human and civil rights for people with intellectual and developmental disabilities.

82

82

The Checkup by Singlecare

MAY 6, 2025

Fentanyl is an opioid medication used as an anesthetic in hospital settings as well as a pain reliever (analgesic) both in and out of the hospital. It plays a key role in various medical procedures, including epidurals. An epidural is a method of pain relief used commonly during childbirth that involves injecting medication into the lower back, in the space around your spinal nerves.

Hospitals 52

Hospitals Labelling FDA 52

Drug Topics

MAY 6, 2025

The use of electronic prescribing can also bridge the gap in clinical history, which can help pharmacists be aware of adverse drug reactions and medication interactions.

315

315

Pharmaceutical Technology

MAY 6, 2025

Developing orphan drugs involves navigating intricate regulatory landscapes, financial risks, and limited clinical data. To rise to these challenges, the biopharma industry continues to develop innovative strategies to bring vital therapies swiftly to rare disease patients.

52

52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

MAY 9, 2025

The most substantial reduction was achieved 2 to 3 years after vaccination with a sustained protective effect lasting up to 8 years

Vaccines 113

Vaccines 113

The Checkup by Singlecare

MAY 6, 2025

Fentanyl is a prescription medication used to manage severe pain, typically during and after surgery. It can be prescribed off-label for certain types of pain, especially severe acute pain or pain caused by cancer. However, outside of its prescribed uses, illegally made fentanyl (IMF) has become a major public health concern due to its potency and high potential for overdose.

Labelling 52

Labelling Dosage Packaging FDA 52

The Guardian - Pharmaceutical Industry

MAY 9, 2025

Providing semaglutide for all those eligible may bring productivity gains as people are able to work more Giving weight loss jabs to everyone eligible for them could boost the UK economy by 4.5bn, according to research. Worldwide, about 3.8 billion people over 25 and just under 750 million children and young people are forecast to be overweight or obese by 2050.

96

96

PharmaVoice

MAY 5, 2025

The two obesity leaders are pulling on all levers to stay on top of the market.

Compounding 165

Compounding 165

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

MAY 6, 2025

Abigail Thomas, PharmD, and Lee A. Kral, PharmD, discuss the evolving role of psilocybin-assisted therapy in palliative care, highlighting current evidence, safety concerns, and how pharmacists can guide patient selection, manage drug interactions, and support education as the therapy moves closer to clinical use.

80

80

STAT

MAY 5, 2025

MILAN — For more than three decades, a charity here has funded research aimed at developing medicines for genetic diseases. Recently, though, it added an unusual new role — as a gene therapy company of sorts.  The charity, the Telethon Foundation, took ownership from a small biotech of a drug that has been approved in Europe to treat an ultra-rare immune disorder called ADA-SCID.

Immunization 141

Immunization 141

The Thyroid Pharmacist

MAY 9, 2025

Over the years of working with people with Hashimotos, it has become clear to me that there is a strong relationship between sex hormones and thyroid hormones. One clients story comes to mind as one that will resonate with many of you. At the time, this client had just turned 40 and started to see some changes in her previously very regular cycle, including mid-cycle spotting and a heavier flow.

Immunization 98

Immunization Compounding 98

Viseven

MAY 9, 2025

When faced with life-or-death treatment decisions, healthcare stakeholders need more than clinical data alone they need a complete picture of both effectiveness and value. Health Economics and Outcomes Research (HEOR) delivers this by uncovering the true impact of therapies on patient outcomes , healthcare costs, and quality of life. For the pharmaceutical industry, HEOR isnt just an analytical tool, its a strategic necessity, shaping decisions that determine market access, pricing, and long-te

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Insurance Communication 52

Pharmacy Times

MAY 9, 2025

The new at-home test aims to increase comfort and screening timeliness through a more accessible method.

FDA 141

FDA 141

The Checkup by Singlecare

MAY 9, 2025

Qulipta ( atogepant ) is a brand-name prescription medication used to prevent migraine headaches (both chronic and episodic migraines ). Currently, Qulipta is not available as a generic medicine. Qulipta is a type of calcitonin gene-related peptide ( CGRP ) receptor antagonist. Migraines are associated with increased levels of a protein called CGRP in the brain, and Qulipta helps to block CGRP receptors from being activated.

Dosage 52

Dosage Generic Medicine Labelling Insurance 52

STAT

MAY 9, 2025

WASHINGTON — U.S. regulators have approved the first  cervical cancer  testing kit that allows women to collect their own sample at home before shipping it to a laboratory, according to a medical device company. Teal Health said Friday the Food and Drug Administration approved its Teal Wand for home use, offering a new way to collect vaginal samples that can detect the HPV virus that causes cervical cancer.

FDA 123

FDA 123

Pharmaceutical Commerce

MAY 9, 2025

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

52

52

Pharmacy Times

MAY 9, 2025

Lacy La Fever, PharmD, MS, discussed outcomes associated with different carboplatin AUC dosing strategies.

65

65

Pharmaceutical Technology

MAY 9, 2025

The US Food and Drug Administration (FDA) has set an "aggressive" timeline to implement genAI across the agency by 30 June 2025.

FDA 52

FDA 52

PharmaVoice

MAY 5, 2025

While clinical trial funding was up, deal-making was down, and new uncertainties are coming into the picture.

100

100

PhRMA

MAY 5, 2025

PBM’s trade association, PCMA, recently launched a campaign to mask growing concerns over their role in the pharmaceutical supply chain and the rising cost of medicine for patients. The campaign is in response to elected officials nationwide joining the congressional momentum in calling for PBM reform. It’s time to rein in middlemen, like PBMs, who use medicines as a profit center and drive up the costs for patients, employers, and taxpayers.

157

157

Pharmacy Times

MAY 9, 2025

These findings demonstrate an association that is independent of the diseases genetic predisposition.

65

65

STAT

MAY 6, 2025

People seeking roles in government are often careful about what they say in public, or at least somewhat hesitant to freely share their opinions. It’s difficult to know exactly what’s going on in their heads.  Not Vinay Prasad. The new top regulator of vaccines and gene therapies at the Food and Drug Administration has never shied away from speaking his mind — whether in academic papers, on social media, or on a diary-esque Substack called “Vinay Prasad

FDA 140

FDA Vaccines 140

pharmaphorum

MAY 6, 2025

A potentially pivotal trial PTC Therapeutics' therapy for Huntington's disease met its primary endpoint, but there are questions about the data

66

66